Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells

Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells

US Patent 10487314 · Granted Nov 26, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of serotonin expression in gut enteroendocrine cells results in conve2021
Inhibition of serotonin expression in gut enteroendocrine cells results in conve2021
Use of aldehyde dehydrogenase as biomarker for beta-cell dysfunction and loss2020
Methods for producing enteroendocrine cells that make and secrete insulin2020
Methods for producing enteroendocrine cells that make and secrete insulin2016
G protein-coupled purinergic receptor Gpr17 mediates orexigenic effects of FoxO12016